title: Maternal metabolic control and perinatal outcome in women with gestational diabetes mellitus treated with lispro or aspart insulin: comparison with regular insulin.
authors: Graziano
authors: G
authors: Di Cianni
authors: Laura
authors: L
authors: Volpe
authors: Alessandra
authors: A
authors: Ghio
authors: Cristina
authors: C
authors: Lencioni
authors: Ilaria
authors: I
authors: Cuccuru
authors: Luca
authors: L
authors: Benzi
authors: Stefano
authors: S
authors: Del Prato
mesh_terms: D001786:Blood Glucose / Q000032:analysis; D015331:Cohort Studies; D016640:Diabetes, Gestational / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007231:Infant, Newborn; D007328:Insulin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D061267:Insulin Aspart; D061268:Insulin Lispro; D007336:Insulin, Isophane / Q000627:therapeutic use*; D018743:Perinatal Care; D011247:Pregnancy; D015430:Weight Gain
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D061267:Insulin Aspart; D061268:Insulin Lispro; D007336:Insulin, Isophane